09.19.2016

Potential fibromyalgia treatment is put on hold

This story on the Tonmya fibromyalgia trial originally appeared on NationalPainReport.com and is being republished here with permission from the editor.  The fibromyalgia community received some bad news earlier this month when Tonix Pharmaceuticals Holding Corp. announced TNX-102 SL (trade name: Tonmya), a low-dose, sublingual form of cyclobenzaprine (Flexeril), did not achieve the primary goal of pain relief in its latest clinical trial. The company will no longer seek approval from the U.S. Food and Drug Administration (FDA) for TNX-102 SL as a treatment for fibromyalgia. TNX-102 SL … [Read more...]

08.30.2016

Proove Fibromyalgia Profile could improve diagnosis, treatment

This article on the Proove Fibromyalgia Profile was first published on NationalPainReport.com. It is being reprinted here with permission from the editor.  The new Proove Fibromyalgia Profile ... Proove Biosciences, a California-based firm specializing in pain medicine, has developed a new tool to help physicians better diagnose and treat fibromyalgia. “The Proove Fibromyalgia Profile is a first-of-its-kind decision-improvement tool that harnesses individualized information to aid in the identification of genetic factors that may contribute to differing clinical pathways behind a … [Read more...]

08.10.2016

Ask the doctors: Is fibromyalgia progressive?

This article, "Ask the Doctors: Is fibromyalgia progressive?," was originally published on NationalPainReport.com. It is being republished here with permission from the editor.  At one time or another, all of us with fibromyalgia have wondered (and maybe even feared), “Is fibromyalgia progressive? Are my symptoms going to worsen over time?” Based on current research, fibromyalgia doesn’t appear to be degenerative, but I know a lot of us who live with this debilitating condition – myself included – question that conclusion. For many of us, it definitely feels like it’s getting worse! … [Read more...]

08.01.2016

EULAR’s revised fibromyalgia recommendations are more of the same

This story about EULAR's revised fibromyalgia recommendations was originally published on NationalPainReport.com. It is being republished here with permission from the editor. Earlier this month, the European League Against Rheumatism (EULAR) released its revised recommendations for the management of fibromyalgia. Unfortunately, there’s nothing really new about EULAR’s latest report. The group’s main conclusion is something every fibromyalgia sufferer has heard from their physician: “Based on meta-analyses, the only ‘strong for’ therapy-based recommendation in the guidelines was … [Read more...]

07.26.2016

What the research really says about using opioids for fibromyalgia

This story on using opioids for fibromyalgia first published on NationalPainReport.com. It is being reprinted here with permission from the editor.  Using opioids for fibromyalgia My fibromyalgia and primary-care doctors have always been united when it comes to one thing: Opioids do not relieve fibromyalgia pain! Early on, I believed them and didn’t question their treatment plans. I figured they must have formed their opinions based on actual clinical trials. Turns out, I was wrong. The reality is there have been no sizable, randomized, double-blind, placebo-controlled studies to … [Read more...]

07.01.2016

Low-dose naltrexone: An effective treatment for ME/CFS?

The following article on low-dose naltrexone for ME/CFS was first published on Prohealth.com. It is being reprinted here with permission from the editor.  Unlike fibromyalgia, there are no FDA-approved treatments for ME/CFS, leaving few options for relieving symptoms. But in recent years, a growing number of patients have started using a little-known drug called low-dose naltrexone (LDN) as an off-label treatment, and now an Alabama-based researcher is planning the first trial to find out if LDN actually reduces the symptoms of ME/CFS. The FDA approved naltrexone to treat addiction to … [Read more...]

05.26.2016

Three new fibromyalgia drugs could be on the way

The following article on new fibromyalgia drugs was first published on NationalPainReport.com and is being reprinted here with permission from the editor. Updated 8/15/17 During the year following my fibromyalgia diagnosis, my rheumatologist prescribed five different drugs in an attempt to relieve my pain. None of them worked. The current fibromyalgia drugs on the market are notoriously ineffective. I remember my rheumatologist sharing a surprising statistic that I’ve since verified through my own research: The most effective fibromyalgia drugs only provide at least a 50 … [Read more...]

05.18.2016

IMC-1 antiviral combo may be next blockbuster fibromyalgia drug

This story on Dr. William "Skip" Pridgen's IMC-1 fibromyalgia drug combination was first published on NationalPainReport.com and is being reprinted here with permission from the editor.  Is IMC-1 the next big thing? A general surgeon with a small practice in Tuscaloosa, Alabama, Dr. William “Skip” Pridgen admits he’s an unlikely creator for the next blockbuster fibromyalgia drug. But the U.S. Food and Drug Administration (FDA) has fast tracked Pridgen’s novel pairing of famciclovir (Famvir), a common antiviral, with celecoxib (Celebrex), an anti-inflammatory arthritis drug, for a … [Read more...]

04.06.2016

More insurance companies now paying for FM/a fibromyalgia test

The story below on the FM/a fibromyalgia test first appeared on NationalPainReport.com. It is being republished here with permission from the editor. (Note: I have no financial interest in EpicGenetics or the FM/a fibromyalgia test.)  Do you have a family member, friend or physician who doubts you have fibromyalgia? Well, there’s a little-known test you may not have heard of that could finally prove you’re really sick. In 2013, Los Angeles-based biomedical company EpicGenetics made international headlines when it introduced FM/a, the first ever fibromyalgia test. While FM/a hasn’t … [Read more...]

02.04.2016

Cymbalta’s withdrawal symptoms prompt lawsuits

As my long-time readers know, I've been closely following the lawsuits related to Cymbalta's withdrawal symptoms on FedUpwithFatigue.com. I was recently asked by Prohealth.com to update their readers on the Cymbalta lawsuits. I'm reprinting that story here with the editor's permission.  I've created a special resources page for anyone interested in Cymbalta's withdrawal symptoms and the pending lawsuits. It includes all of FedUpwithFatigue’s Cymbalta-related posts, links to news stories, support groups and other useful information. Update 10/25/16: The Cymbalta lawsuits have been … [Read more...]

Wordpress content guard plugin by JaspreetChahal.org